Variant report

Variant	esv3440304
Chromosome Location	chr3:67925362-67954660
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:67951890..67952870-chr3:68066397..68066948,2	MCF-7	breast:
2	chr3:67951814..67952581-chr3:68255379..68256164,2	MCF-7	breast:
3	chr3:67952201..67952773-chr3:68925063..68925992,2	MCF-7	breast:
4	chr3:67951881..67952772-chr3:68305559..68306337,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM19A1-1	chr3:67939433-67939460	NONHSAT090326
2	lnc-FAM19A1-1	chr3:67939434-67939460	XLOC_002693
3	lnc-FAM19A1-1	chr3:67939434-67939533	ENSG00000241316
4	lnc-FAM19A1-1	chr3:67939434-67939533	NR_109992

No data

Variant related genes	Relation type
E2F3	miRNA target sites

Extended variants
information (count: 581 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:581 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs73837225	chr3:67925362-67925363	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs375890289	chr3:67925409-67925410	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs183735711	chr3:67925419-67925420	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs543485798	chr3:67925469-67925470	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs563274426	chr3:67925505-67925506	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs529001627	chr3:67925547-67925548	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs542409121	chr3:67925610-67925611	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs540854265	chr3:67925629-67925630	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs187611441	chr3:67925664-67925665	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs559596463	chr3:67925714-67925715	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs528382722	chr3:67925729-67925730	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs551744880	chr3:67925756-67925757	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs116621434	chr3:67925779-67925780	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs533205093	chr3:67925802-67925803	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs79697768	chr3:67925829-67925830	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs144060242	chr3:67925842-67925843	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs535948605	chr3:67925843-67925844	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs528712200	chr3:67925866-67925867	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs555501794	chr3:67925880-67925881	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs62254937	chr3:67925886-67925887	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs534984064	chr3:67925888-67925889	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs564211649	chr3:67925912-67925913	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs558060503	chr3:67925917-67925918	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs11711015	chr3:67925920-67925921	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs536610657	chr3:67925929-67925930	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs73837226	chr3:67925959-67925960	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs573612267	chr3:67926017-67926018	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs542746273	chr3:67926030-67926031	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs377304293	chr3:67926111-67926112	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs559581335	chr3:67926118-67926119	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs573100563	chr3:67926143-67926144	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs545308264	chr3:67926147-67926148	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs146449461	chr3:67926218-67926219	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs191728725	chr3:67926220-67926221	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs56087100	chr3:67926231-67926232	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs549858650	chr3:67926236-67926237	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs140843982	chr3:67926241-67926242	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs546981800	chr3:67926250-67926251	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs184320115	chr3:67926341-67926342	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs144603041	chr3:67926360-67926361	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs565508240	chr3:67926373-67926374	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs565915656	chr3:67926385-67926386	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs534924163	chr3:67926466-67926467	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs186789130	chr3:67926468-67926469	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs1485340	chr3:67926488-67926489	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs537756072	chr3:67926562-67926563	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs192721673	chr3:67926576-67926577	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs140359907	chr3:67926639-67926640	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs552875040	chr3:67926648-67926649	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs150353970	chr3:67926649-67926650	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Acute myeloid leukemia	20729466	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16608533	CNVD
Prostate cancer	21965145	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	19490591	CNVD
Autism	18414403	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-small cell lung cancer	20864512	CNVD
Metastatic melanoma	17975146	CNVD
Breast cancer	21509527	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Autism	22102821	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Prostate cancer	17217626	CNVD
Urothelial cell carcinoma	18451213	CNVD
Alzheimer''s disease	22166940	CNVD
Mental retardation	20848658	CNVD
Breast cancer	17142309	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	21364760	CNVD
lymphocytic leukemia	21291569	CNVD

Chromatin state (count:32 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:67922000-67925400	Weak transcription	Liver	Liver
2	chr3:67925400-67925800	Enhancers	A549	lung
3	chr3:67925400-67927000	Enhancers	Liver	Liver
4	chr3:67925400-67927600	Enhancers	HepG2	liver
5	chr3:67925600-67926000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr3:67925600-67926800	Enhancers	Hela-S3	cervix
7	chr3:67925800-67926400	Flanking Active TSS	A549	lung
8	chr3:67925800-67937400	Weak transcription	Aorta	Aorta
9	chr3:67926000-67926400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr3:67926400-67926600	Active TSS	A549	lung
11	chr3:67926400-67927000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr3:67926400-67927000	Enhancers	Ovary	ovary
13	chr3:67926400-67928000	Enhancers	Fetal Intestine Large	intestine
14	chr3:67926600-67926800	Flanking Active TSS	A549	lung
15	chr3:67926600-67927200	Enhancers	Rectal Mucosa Donor 31	rectum
16	chr3:67926600-67928000	Enhancers	Fetal Intestine Small	intestine
17	chr3:67927000-67927400	Flanking Active TSS	Liver	Liver
18	chr3:67927200-67927600	Weak transcription	Rectal Mucosa Donor 31	rectum
19	chr3:67927400-67928000	Enhancers	Liver	Liver
20	chr3:67927600-67928000	Enhancers	Rectal Mucosa Donor 31	rectum
21	chr3:67934400-67934800	Enhancers	Fetal Brain Female	brain
22	chr3:67946200-67947400	Enhancers	Fetal Intestine Small	intestine
23	chr3:67946200-67947600	Enhancers	Fetal Intestine Large	intestine
24	chr3:67946400-67946600	Enhancers	Fetal Brain Male	brain
25	chr3:67946400-67947800	Enhancers	Liver	Liver
26	chr3:67946600-67947200	Weak transcription	Fetal Brain Male	brain
27	chr3:67947200-67948600	Enhancers	Fetal Brain Male	brain
28	chr3:67948000-67948400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr3:67948000-67948800	Enhancers	Fetal Kidney	kidney
30	chr3:67948000-67949600	Enhancers	Fetal Brain Female	brain
31	chr3:67948200-67948800	Enhancers	Primary B cells from peripheral blood	blood
32	chr3:67949200-67949600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links